Key opinions on SPIRIVA® Respimat® in asthma

We present a series of video interviews with leading experts in asthma and respiratory medicine, as well as family medicine practitioners.

Insights into patient experiences of the Respimat® inhaler - Dr Dennis Doherty

Dr Dennis Doherty is a pulmonologist in the US. Here he shares insights from his own clinic about patient experiences of using the Respimat® inhaler and stresses the important role of patient education on inhaler devices for asthma.


What do the 2017 GINA strategy updates mean for your patients? - Professor Nicolas Roche

Professor Nicolas Roche is a pulmonologist from France. Here he explains why expanding the range of treatment options recommended in the 2017 GINA strategy is an important development for patients with asthma.


Acetylcholine in the airways: more than a neurotransmitter! - Professor Reinoud Gosens

Professor Reinoud Gosens, a pulmonologist from the Netherlands, explores the latest developments in the scientific literature about the emerging role of non-neuronal acetylcholine in airway inflammation and remodelling. This video also features insights into the acute and long-term effects of acetylcholine in the lungs.


Practical guidance for identifying patients with uncontrolled asthma - Professor Nicolas Roche

Professor Nicolas Roche, a pulmonologist from France, highlights the challenges of uncontrolled asthma, explores the value of validated questionnaires (e.g. ACT and ACQ) in identifying sympotmatic patients and provides practical guidance on questioning patients about their asthma symptoms.


Tiotropium Respimat® in asthma – Professor David Halpin

Professor Halpin describes the role of acetylcholine in the pathophysiology of asthma and considers the efficacy and safety of SPIRIVA® (tiotropium) Respimat® as an add-on therapy in the treatment of patients with symptomatic asthma.


Real-life impact of symptomatic asthma on patients – Professor Eric Bateman

Professor Bateman looks at some common misconceptions around asthma and reveals the societal burden of asthma. The video also features patients discussing the impact asthma symptoms have on their daily lives at school, at work and at home.


Long-acting bronchodilators and the benefits of the Respimat® inhaler device – Dr Len Fromer

Dr Fromer is an asthmatic and a family medical practitioner in the US. Here he talks about the causes of impairment, as well as the options available to doctors when treating adult patients with asthma including long-acting bronchodilators.


SPIRIVA® Respimat® in clinical practice – a case study from a UK GP – Dr Kevin Gruffydd-Jones

UK based General Practitioner Dr Gruffydd-Jones describes his experience of managing a highly atopic 48 years old patient with a history of rhinitis and eczema treated with SPIRIVA® Respimat®.



The right questions to ask an asthma patient – Dr Andrew Menzies-Gow

Dr Menzies-Gow explains the questioning techniques used in his clinics and the value of validated questionnaires, particularly the Asthma Control Test (ACT) and Juniper Asthma Control Questionnaire (ACQ), to assess symptom control.


The importance of primary care in asthma – Dr Kevin Gruffydd-Jones

Dr Gruffydd-Jones explains the role of primary care professionals in regularly monitoring asthma patients and stresses the need for good patient/doctor dialogue to ensure asthma management plans remain up-to-date and optimised.



The importance of multidisciplinary care in asthma – Dr Miguel Rodriguez

Dr Rodriguez highlights the value of shared decision-making with asthma patients and empowering patients to self-manage their asthma symptoms. He stresses the importance of nursing staff in the delivery of improved multidisciplinary care.